Institutional investors purchased a net $2.3 million shares of GENE during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 28.48% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 1.1 Million shares of Genetic Technologies Ltd
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 1.1 Million shares of Genetic Technologies Ltd